Quoin Pharmaceuticals Extends Exclusive Distribution Agreement with Er-Kim for its Lead Asset, QRX00
ASHBURN, Va., March 01, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a specialty...
top of page
Search
Feb 10, 20223 min
Quoin Pharmaceuticals Signs Exclusive Distribution Agreement with Er-Kim for its Lead Asset, QRX003
ASHBURN, Va., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a specialty...
Jan 31, 20222 min
Aeterna Zentaris & Er-Kim Announce Partnership to Commercialize Macrilen in Eight European Countries
Istanbul, Turkey – January 31, 2022 – Er-Kim, a regional specialty pharmaceutical company, announced today the signature of an exclusive...
Jun 30, 20214 min
Er-Kim Announces Distribution Agreement and Acceptance of Application for BRUKINSA® in Turkey
Er-Kim Announces Exclusive Distribution Agreement and Acceptance of Priority New Drug Application for BTK Inhibitor BRUKINSA®...
Jun 29, 20216 min
Distribution agreement with Er-Kim for Bulgaria and Romania
Extends relationship with Er-Kim following Turkey agreement for Alkindi® and Efmody® Diurnal Group plc (AIM: DNL), the specialty...
Latest News Here
bottom of page